- Company Overview for ORGANON PHARMA (UK) LIMITED (00820771)
- Filing history for ORGANON PHARMA (UK) LIMITED (00820771)
- People for ORGANON PHARMA (UK) LIMITED (00820771)
- More for ORGANON PHARMA (UK) LIMITED (00820771)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
25 Mar 2024 | TM01 | Termination of appointment of Simon Khalid Hussain as a director on 29 February 2024 | |
25 Mar 2024 | AP01 | Appointment of Isabel Vandenberk as a director on 1 March 2024 | |
22 Mar 2024 | TM01 | Termination of appointment of Torben Dahl as a director on 29 February 2024 | |
22 Mar 2024 | TM01 | Termination of appointment of Simon Nicholson as a director on 15 February 2024 | |
22 Mar 2024 | AP01 | Appointment of Ms Sandy Lindsey as a director on 1 March 2024 | |
22 Mar 2024 | AP01 | Appointment of Mr Michael Whale as a director on 1 March 2024 | |
21 Mar 2024 | AP01 | Appointment of Mr Josef Ralph Laskowski as a director on 1 March 2024 | |
05 Oct 2023 | AA | Full accounts made up to 31 December 2022 | |
10 Jul 2023 | CS01 | Confirmation statement made on 10 July 2023 with no updates | |
13 Sep 2022 | AA | Full accounts made up to 31 December 2021 | |
13 Jul 2022 | CS01 | Confirmation statement made on 10 July 2022 with no updates | |
20 Dec 2021 | RP04AP01 | Second filing for the appointment of Torben Dahl as a director | |
20 Sep 2021 | AP01 |
Appointment of Dahl Torben as a director on 28 May 2021
|
|
20 Sep 2021 | AP01 | Appointment of Simon Khalid Hussain as a director on 28 May 2021 | |
02 Sep 2021 | AA | Full accounts made up to 31 December 2020 | |
21 Jul 2021 | CS01 | Confirmation statement made on 10 July 2021 with updates | |
11 Jun 2021 | PSC02 | Notification of Organon & Co., Inc. as a person with significant control on 2 June 2021 | |
11 Jun 2021 | PSC07 | Cessation of Merck & Co., Inc. as a person with significant control on 2 June 2021 | |
11 Jun 2021 | PSC02 | Notification of Merck & Co., Inc. as a person with significant control on 22 March 2021 | |
11 Jun 2021 | PSC07 | Cessation of Merck Sharp & Dohme (Uk) Limited as a person with significant control on 22 March 2021 | |
10 Jun 2021 | TM01 | Termination of appointment of Ebru Can Temucin as a director on 28 May 2021 | |
08 Jun 2021 | TM01 | Termination of appointment of David Peacock as a director on 28 May 2021 | |
07 Jun 2021 | AP03 | Appointment of John Albert Parsons as a secretary on 28 May 2021 | |
07 Jun 2021 | TM02 | Termination of appointment of Amy Davies as a secretary on 1 June 2021 | |
15 Apr 2021 | AD01 | Registered office address changed from Hertford Road Hoddesdon Hertfordshire EN11 9BU to The Hewett Building 14 Hewett Street London EC2A 3NP on 15 April 2021 |